Our Insights
Hazelbrook shares its deep expertise and professional knowledge to bring you news, legal insights and media updates.
Hazelbrook Legal launches Litigation, Disputes & International Arbitration practice
22 June 2026.
Today Hazelbrook Legal announced the launch of its Litigation, Disputes & International Arbitration practice, led by newly appointed Partner, Josh Jefferies.
MAC to the Future: What Mayne Pharma Means for Deal Drafting
The Supreme Court of New South Wales has delivered a significant ruling in Re Mayne Pharma Group Limited [2025] NSWSC 1204, marking one of the most detailed examinations of material adverse change (MAC) clauses in Australian M&A history. It is a decisive moment for deal makers and legal practitioners, confirming that MAC provisions are not exit ramps for buyer’s remorse.
APRA’s 2025–26 Corporate Plan: Getting the Balance Right Between Resilience and Efficiency
APRA’s 2025-26 Corporate Plan sets out the regulator’s strategic objectives for the next four years and supervisory priorities for the next 12 to 18 months.
MAC ATTACK: The Power and Pitfalls of Material Adverse Change Clauses in M&A Deals
The high-stakes legal standoff between Cosette Pharmaceuticals and Mayne Pharma offers a timely reminder of a critical issue for both buyers and sellers in mergers and acquisitions: how material adverse change (MAC) clauses are drafted, negotiated, and ultimately enforced.
Crypto-Linked Products and AFSL Requirements: Key Takeaways from the Recent Court Decision
The Full Federal Court has overturned a previous decision that found Block Earner’s fixed-yield “Earner” product to be a financial product requiring an Australian financial services licence (AFSL).
Load Next 5
↓